Revolutionizing the way chronic back pain is managed
We are bringing a breakthrough technology to treat and manage chronic low back pain (CLBP), by correcting the neuro-mechanical root cause, rather than the symptom, for long-term prevention.
Back pain is the leading cause of disability worldwide
Introducing L-PACT:
An innovative neuro-mechanical wearable CLBP management system
Assessment
Dynamic low back posture
AI sensing
Training-to-Treat
Proprietary auto-correction
and responsive algorithms
Prevention
Neuromuscular self-learning
and CLBP prediction
Structural misalignment and poor posture over time in the lower part of our spine, our lumbo-pelvic region, mostly leads to chronic low back pain (CLBP). These asymmetries at the Lumbo- Pelvic Load Distribution Axis (LDA) can alter the body’s mechanics and put various body segments under strain contributing to musculoskeletal pain and long-term deterioration.
The L-PACT brings a new approach to restore the correct loading of the lumbo- pelvic structures. Using AI sensing and automated counter compressive force pressures, the L-PACT assesses and restores pelvic dynamic postural balance. By training for a short walk with the device, the L-PACT empowers clinicians to enable neuromuscular learning and brain retraining leading to long-term CLBP prevention.
L-PACT Advantages
A groundbreaking technology to analyze and correct dynamic spinal posture
Based on vast clinical know-how and innovative technological advances, our proprietary technology analyzes and corrects the neuro-mechanical root cause of back pain.
- AI sensing assesses biomechanical faults of dynamic low back posture
- Automated counter compressive force pressures restore lumbo-pelvic balance (symmetry)
- Data-driven algorithms optimize spinal functional performance
- Corrective actionable insights improve awareness and patient engagement
Supporting scientific literature
The innovative technology behind L-PACT is based on extensive research conducted in the field. Key research published in renowned peer-reviewed journals supports its unique approach to address asymmetries in lumbo-pelvic motion and posture for pain reduction and long-term prevention.
About Us
Symetrify aims to set a new standard of care in monitoring and treating neuro-musculoskeletal health.
In a proof-of-concept study involving 100 patients, 98% of all patients improved, with 42% of patients improving after just 1 treatment!
Symetrify will initially target the $34 billion US physical therapy market, followed by the sports and fitness industry and the workplace environment.
Symetrify’s proprietary technology platform can also be applied to numerous neuromuscular conditions, including treating neck pain, shoulder pain, and sports injuries, all multi-billion-dollar market opportunities.
The company is collaborating with eHealth Ventures, a digital health incubator providing access to world-class clinical, operational and business networks.
Team and Advisory
Dr. Ami Eyal
Founder, CMO & R&D
Dana Chanan
CEO
Talor Sax
Chairman of the Board
Ophir Shahaf
Business Development
Shay Yulzary
Mechanical Engineer
(MSc), MBA
Tomer Bruchiel
Electrical Engineer (BSc)